JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2009, 58(1):21-27

Chitosan pellets produced by extrusion-spheronisation

L. Janovská*, G. Škrabáková, D. Vetchý, M. Rabišková
Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav technologie léků

Chitosan, an intensively studied semisynthetic polymer, has many possible uses due to its special parameters. Chitosan is also presently useful as an excipient in pharmaceutical industry due to its binding, mucoadhesive, viscosity-increasing and film-coating properties which depend on its concentration. Pellets, spherical multiple dosage forms, make possible to solve a lot of problems with oral administration of drugs thanks to its unique properties. In our experiment, matrix pellets containing theophyllin were made by extrusion/spheronisation method. Microcrystalline cellulose and chitosan with 91% degree of deacetylation in concentrations of 25, 35, 45, 55, 65 and 70% were used as matrix-forming excipients. The influence of chitosan concentration on liberation of drug was observed in media with different pH values. The most prolonged theophyllin release (3 hours) was achieved in phosphate buffer of pH 6.8 and chitosan concentration of 25-35%.

Keywords: chitosan; pellets; sustained release; extrusion, spheronisation
Grants and funding:

Tato práce byla realizovaná za finanční podpory grantu IGA VFU Brno 74/2007/FaF.

Received: January 8, 2009; Accepted: January 20, 2009; Published: January 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janovská L, Škrabáková G, Vetchý D, Rabišková M. Chitosan pellets produced by extrusion-spheronisation. Čes. slov. farm. 2009;58(1):21-27.
Download citation

References

  1. Kolektiv autorů: Český lékopis 2002. Praha: Grada Publishing 2002; 460-462, 1934-1936.
  2. Säkkinen, M.: Academic Dissertation, University of Helsinki 2003; 3-8.
  3. www.unige.ch/sciences/pharm/fagal/of-these.htm., 10. 1. 2007
  4. Illum, L.: Pharm. Res., 1998; 15(9), 1326-1331. Go to original source... Go to PubMed...
  5. Kumar, M. N. V. R.: React. Funct. Polym., 2002; 46, 1-27. Go to original source...
  6. Säkkinen, M., Seppälä, U., Henänen, P. et al.: Eur. J. Pharm. Biopharm., 2002; 54, 33-40. Go to original source... Go to PubMed...
  7. Rinaudo, M.: Prog. Polym. Sci., 2006; 31, 603-632. Go to original source...
  8. Sabnis, S., Block, L. H.: Int. J. Biol. Macromol., 2000; 27, 181-186. Go to original source... Go to PubMed...
  9. Bajerová, M., Gajdziok, J., Dvořáčková, K. et al.: Čes. slov. Farm., 2008; 57, 63-69.
  10. Kollár, P., Suchý, P., Muselík, J. et al.: Čes. slov. Farm., 2008; 57, 11-16.
  11. Lowman, A. M., Peppas, N. A.: In: Encyclopedia of controlled drug delivery, Mathowitz E., Volume 1, 1999, s. 397-415.
  12. Dodane, V., Vilivalam, V. D.: Pharm. Sci. Tech. To., 1998; 4 (6), 246-253. Go to original source...
  13. Masteiková, R., Chalupová, Z., Šklubalová, Z.: Medicina, 2003; 39 (Suppl. 2), 19-24.
  14. Chandy, T., Sharma, Ch. P.: Biomaterials, 1993; 14 (12), 939-944. Go to original source... Go to PubMed...
  15. Haznos, L., Langer, I., Gyamathy, M.: Drug Dev. Ind. Pharm., 1992; 18, 409-412. Go to original source...
  16. Kolektiv autorů: Český lékopis 2005, Doplněk 2006. Praha: Grada Publishing 2006; 3361-3362.
  17. Sienkiewicz, G., Pereira, R., Rudnic, E. M.: Drug Dev. Ind. Pharm., 1997; 23, 173-177. Go to original source...
  18. Rabišková, M., Häring, A., Minczingerová, K. et al.: Chem. Listy, 2007; 101, 70-77.
  19. Krejčová, K., Rabišková, M., Vetchý, D. et al.: Drug Dev. Ind. Pharm., 2006; 32, 585-593. Go to original source... Go to PubMed...
  20. El Saleh, F., Kleinebudde, P.: Pharm. Tech. Europe, 1998; 10, 18-22.
  21. Rodrigues, E. C., Torrado, J. J., Nikolakakis, I. et al.: Drug Dev. Ind. Pharm., 2001; 27, 847-855. Go to original source... Go to PubMed...
  22. Sienkiewicz, G., Pereira, R., Rudnic, E. M. et al.: Drug Dev. Ind. Pharm., 1997; 23, 173-182. Go to original source...
  23. Vertommen J., Kinget R.: Drug Dev. Ind. Pharm., 1997; 23, 39-46. Go to original source...
  24. Robinson, J. R., Lee, V. H.: In: Controlled Drug Delivery. New York and Basel: Marcel Dekker 1987; 388-396. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.